Literature DB >> 20802975

Characterization of angiotensin-converting enzymes 1 and 2 in the soleus and plantaris muscles of rats.

T Fernandes1, N Y Hashimoto, E M Oliveira.   

Abstract

Angiotensin-converting enzymes 1 (ACE1) and 2 (ACE2) are key enzymes of the renin-angiotensin system, which act antagonistically to regulate the levels of angiotensin II (Ang II) and Ang-(1-7). Considerable data show that ACE1 acts on normal skeletal muscle functions and architecture. However, little is known about ACE1 levels in muscles with different fiber compositions. Furthermore, ACE2 levels in skeletal muscle are not known. Therefore, the purpose of this study was to characterize protein expression and ACE1 and ACE2 activities in the soleus and plantaris muscles. Eight-week-old female Wistar rats (N = 8) were killed by decapitation and the muscle tissues harvested for biochemical and molecular analyses. ACE1 and ACE2 activities were investigated by a fluorometric method using Abz-FRK(Dnp)P-OH and Mca-YVADAPK(Dnp)-OH fluorogenic substrates, respectively. ACE1 and ACE2 protein expression was analyzed by Western blot. ACE2 was expressed in the skeletal muscle of rats. There was no difference between the soleus (type I) and plantaris (type II) muscles in terms of ACE2 activity (17.35 ± 1.7 vs 15.09 ± 0.8 uF·min(-1)·mg(-1), respectively) and protein expression. ACE1 activity was higher in the plantaris muscle than in the soleus (71.5 ± 3.9 vs 57.9 ± 1.1 uF·min(-1)·mg(-1), respectively). Moreover, a comparative dose-response curve of protein expression was established in the soleus and plantaris muscles, which indicated higher ACE1 levels in the plantaris muscle. The present findings showed similar ACE2 levels in the soleus and plantaris muscles that might result in a similar Ang II response; however, lower ACE1 levels could attenuate Ang II production and reduce bradykinin degradation in the soleus muscle compared to the plantaris. These effects should enhance the aerobic capacity necessary for oxidative muscle activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802975     DOI: 10.1590/s0100-879x2010007500088

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  13 in total

1.  Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays.

Authors:  Kim Brint Pedersen; Srinivas Sriramula; Kavaljit H Chhabra; Huijing Xia; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-31       Impact factor: 3.619

2.  ACE Inhibitors and Sarcopenia: Covering All the BASEs?

Authors:  Jochen Springer; Stephan von Haehling
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

Review 3.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

4.  Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.

Authors:  Masao Takeda; Koichi Yamamoto; Yukihiro Takemura; Hikari Takeshita; Kazuhiro Hongyo; Tatsuo Kawai; Hiroko Hanasaki-Yamamoto; Ryosuke Oguro; Yoichi Takami; Yuji Tatara; Yasushi Takeya; Ken Sugimoto; Kei Kamide; Mitsuru Ohishi; Hiromi Rakugi
Journal:  Diabetes       Date:  2012-08-29       Impact factor: 9.461

5.  Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats.

Authors:  Igor Lucas Gomes-Santos; Tiago Fernandes; Gisele Kruger Couto; Julio César Ayres Ferreira-Filho; Vera Maria Cury Salemi; Fernanda Barrinha Fernandes; Dulce Elena Casarini; Patricia Chakur Brum; Luciana Venturini Rossoni; Edilamar Menezes de Oliveira; Carlos Eduardo Negrao
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

Review 6.  Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences.

Authors:  Aline V Bacurau; Telma F Cunha; Rodrigo W Souza; Vanessa A Voltarelli; Daniele Gabriel-Costa; Patricia C Brum
Journal:  Oxid Med Cell Longev       Date:  2016-01-19       Impact factor: 6.543

7.  Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis.

Authors:  Wei Zhang; Yi-Zhi Xu; Bo Liu; Rong Wu; Ying-Ying Yang; Xiao-Qiu Xiao; Xia Zhang
Journal:  ScientificWorldJournal       Date:  2014-01-14

8.  ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis.

Authors:  Cecilia Riquelme; María José Acuña; Javiera Torrejón; Daniela Rebolledo; Daniel Cabrera; Robson A Santos; Enrique Brandan
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

9.  The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care.

Authors:  E I Gusev; M Yu Martynov; A N Boyko; I A Voznyuk; N Yu Latsh; S A Sivertseva; N N Spirin; N A Shamalov
Journal:  Neurosci Behav Physiol       Date:  2021-02-18

10.  Commentaries on Viewpoint: The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.

Authors:  Ai Lyn Tan; Matthew Farrow; John Biglands; Ricardo J. Fernandes; J. Arturo Abraldes; Flávio Antônio de Souza Castro; Hiago L.R. de Souza; Rhai A. Arriel; Anderson Meireles; Moacir Marocolo; José Manuel González-Rayas; Ana Lilia Rayas-Gómez; Fadia Norma Mobayed-Vega; José Manuel González-Yáñez; Daniel M. Hirai; Michael D. Belbis; Michael J. Holmes; Nainoa Calvo; Scott K. Ferguson; Tiago Fernandes; Edilamar Menezes Oliveira; Matiram Pun; Sanjeeb S. Bhandari
Journal:  J Appl Physiol (1985)       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.